Yi-Cheng Ni, MD, PhD, Department of Radiology, University Hospitals, K.U. Leuven, Herestraat 49, B-3000, Leuven, Belgium.
With a medical degree in China, upon his PhD in 1995 at University of Leuven, Belgium, Yi-Cheng Ni was nominated a permanent professorship at Faculty of Medicine where he initiated a laboratory of experimental radiology. Over the last 20 years, he has focused his scientific interests on the topics related to life-threatening disorders including cancer and cardiovascular diseases. With his expertise in biomedical imaging, interventional therapy and contrast agent research, he has established a series of platforms for preclinical evaluation of diagnostics/therapeutics, developed a virtual biopsy method for noninvasive characterization of liver tumors using contrast enhanced MRI, discovered necrosis-avid contrast agents (NACAs), invented a dual targeting cancer theragnostic strategy, trained tens of postgraduate students including the first PhD worldwide on cancer radiofrequency ablation (RFA), filed a dozen of patent applications, published numerous SCI journal papers and book chapters, edited/reviewed for many academic journals, worked as a guest professor in many foreign universities and institutes, coordinated/participated in several EU/national projects, served as an evaluation expert for organizations such as Chinese Academy of Sciences and European Commission (FP7), and received many academic honors including Herbert M Stauffer Award (1993) and Elliott Lasser Award (2009). Innovative, translational and longstanding research has ever been a pursuit in his academic career.